Literature DB >> 16911685

Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment.

Andreas Schäffler1, Alois Fürst, Christa Büchler, Gisela Paul, Gerhard Rogler, Jürgen Schölmerich, Hans Herfarth.   

Abstract

BACKGROUND: Creeping fat represents a characteristic feature of Crohn's disease (CD) and adipose tissue is currently being recognized as a complex compartment secreting highly active molecules. Pro- or anti-inflammatory adipose tissue-derived secretory products (adipocytokines) might play a role in the pathogenesis of CD.
METHODS: Adipose tissue specimens were obtained from creeping fat contiguous to the involved intestine of 10 patients with CD. Mesenteric adipose tissue specimens resected in 13 patients with colon cancer (CC) and in seven patients with diverticulitis (DIV) served as controls. Three fat tissue specimens per well and n = 6-8 wells per patient were incubated ex vivo for 24 h. The release of regulated on activation, T-cell expressed and secreted (RANTES) and interleukin (IL)-10 into the supernatant was measured by ELISA.
RESULTS: Both RANTES and IL-10 secretion could be demonstrated from total adipose tissue explants. The RANTES secretion is increased from creeping fat in CD (3691 +/- 597 pg/g fat per 24 h) when compared to mesenteric adipose tissue from patients with CC (1690 +/- 191 pg/g fat per 24 h; P < 0.0001) or DIV (1672 +/- 336 pg/g fat per 24 h; P < 0.0001). In contrast, IL-10 secretion is downregulated significantly only in patients with DIV (1418 +/- 180 pg/g fat per 24 h; P = 0.016) when compared to CC patients (2368 +/- 259 pg/g fat per 24 h). Crohn's disease patients receiving steroids had a higher secretion rate of RANTES and IL-10.
CONCLUSIONS: Both RANTES and IL-10 secretion can be detected from mesenteric adipose tissue and from creeping fat. The elevated RANTES and IL-10 secretion from creeping fat in CD is not due to a CD-specific effect but caused by steroid treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911685     DOI: 10.1111/j.1440-1746.2006.04300.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

Review 1.  The "creeping fat sign"-really diagnostic for Crohn's disease?

Authors:  Werner A Golder
Journal:  Int J Colorectal Dis       Date:  2008-09-25       Impact factor: 2.571

2.  Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.

Authors:  Kimberley W J Van Der Sloot; Amit D Joshi; Danielle R Bellavance; Katherine K Gilpin; Kathleen O Stewart; Paul Lochhead; John J Garber; Cosmas Giallourakis; Vijay Yajnik; Ashwin N Ananthakrishnan; Behrooz Z Alizadeh; Ramnik J Xavier; Hamed Khalili
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

Review 3.  Mesenchymal stem cell secretome and regenerative therapy after cancer.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis; Vera S Donnenberg; Albert D Donnenberg
Journal:  Biochimie       Date:  2013-06-05       Impact factor: 4.079

4.  Perinodal adipose tissue and mesenteric lymph node activation during reactivated TNBS-colitis in rats.

Authors:  Simone Coghetto Acedo; Erica Martins Ferreira Gotardo; Janilda Martins Lacerda; Caroline Candida de Oliveira; Patrícia de Oliveira Carvalho; Alessandra Gambero
Journal:  Dig Dis Sci       Date:  2011-03-06       Impact factor: 3.199

5.  Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in intestinal and mesenteric fat tissue of Crohn's disease.

Authors:  Raquel F Leal; Marciane Milanski; Maria de Lourdes S Ayrizono; Andressa Coope; Viviane S Rodrigues; Mariana Portovedo; Luiza M F Oliveira; João J Fagundes; Cláudio S R Coy; Lício A Velloso
Journal:  Int J Clin Exp Med       Date:  2013-01-26

6.  Abdominal visceral adipose tissue is associated with unsuspected pulmonary embolism on routine CT scans in patients with gastrointestinal cancer.

Authors:  Xiaojuan Xiao; Yao Wang; Ying Gao; Qiuxia Xie; Xuhui Zhou; Ling Lin; Ilona A Dekkers; Hildo J Lamb
Journal:  Br J Radiol       Date:  2019-10-09       Impact factor: 3.039

7.  Apoptosis and inflammation: role of adipokines in inflammatory bowel disease.

Authors:  Venkatesh Ponemone; Ali Keshavarzian; Marc I Brand; Theodore Saclarides; Herand Abcarian; Robert J Cabay; Emma Fletcher; Bianca Larsen; Larry J Durstine; Giamila Fantuzzi; Raja Fayad
Journal:  Clin Transl Gastroenterol       Date:  2010-10-21       Impact factor: 4.488

8.  Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.

Authors:  Andreas Schäffler; Martina Zeitoun; Hella Wobser; Christa Buechler; Charalampos Aslanidis; Hans Herfarth
Journal:  Cardiovasc Diabetol       Date:  2007-02-13       Impact factor: 9.951

9.  CSF-1 regulates the function of monocytes in Crohn's disease patients in remission.

Authors:  Juan Camilo Nieto; Carlos Zamora; Elisabet Cantó; Esther Garcia-Planella; Jordi Gordillo; Maria Angels Ortiz; Cándido Juárez; Silvia Vidal
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

Review 10.  Bacterial translocation - impact on the adipocyte compartment.

Authors:  Tassilo Kruis; Arvind Batra; Britta Siegmund
Journal:  Front Immunol       Date:  2014-01-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.